HCPCS Level IIdrugActive
J3032
Inj. eptinezumab-jjmr 1 mg
BETOS: O1E
Effective: 2020-10-01
Referenced in 2 policies
Description
Injection, eptinezumab-jjmr, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vyepti
Manufacturer
Lundbeck Pharmaceuticals LLC
HCPCS Dosage
1 MG
Billing Units
100.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.